Nautilus Biotechnology, Inc.

NASDAQ:NAUT

Biotechnology

Healthcare
$2.43 +2.06%

+$0.05 today

Market cap
$309.51M
Beta
0.75
P/E (TTM)
-4.9
EPS (TTM)
-$0.45
52W Low $0.62High $4.31

Volume 4.55M

Average 0.40M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$66.84M

FY 2025 · Annual

Net Income

-$59.00M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue2.84M3.42M5.71M6.35M6.47M
Gross Profit(2.84M)(3.42M)(5.71M)(6.35M)(6.47M)
Gross Margin—————
Research & Development26.51M36.46M47.25M50.48M41.11M
Selling, General & Admin21.15M23.75M28.9M31M25.73M
Operating Expenses47.66M60.2M70.45M75.12M60.37M
Depreciation & Amortization2.84M3.42M1.85M6.35M6.47M
EBITDA(47.47M)(54.51M)(61.83M)(64.43M)(52.54M)
EBITDA Margin—————
Operating Income(50.5M)(63.62M)(76.15M)(81.48M)(66.84M)
Operating Margin—————
Interest Income329K5.82M12.55M10.78M7.87M
Interest Expense05.82M000
Other Income / Expenses183K5.69M12.48M10.7M7.84M
Income Before Tax(50.32M)(57.92M)(63.68M)(70.78M)(59M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(50.32M)(57.92M)(63.68M)(70.78M)(59M)
Net Margin—————
EPS (Basic)(0.60)(0.46)(0.51)(0.56)(0.47)
EPS (Diluted)(0.60)(0.46)(0.51)(0.56)(0.47)
Weighted Avg Shares84.46M124.59M124.92M125.43M126.26M
Weighted Avg Shares (Diluted)84.46M124.59M124.92M125.43M126.26M

NAUT Earnings Waterfall · TTM

NASDAQ:NAUT · Revenue to Net Income

Key Ratios

EPS$-0.46
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$57.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.46, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 3, 2026
10-QQuarterly reportOct 27, 2026
8-KCurrent reportOct 27, 2026
EFFECTEFFECT filingSep 18, 2026
424B5424B5 filingSep 18, 2026

How much revenue does NAUT generate?

Nautilus Biotechnology, Inc. (NAUT) reported $0.00 of revenue in fiscal 2025.

Is NAUT profitable?

Nautilus Biotechnology, Inc. (NAUT) reported -$59.00M of net income.